(HLNE) Hamilton Lane - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4074971064

Private Equity, Venture Capital, Fund Of Funds, Direct Credit, Real Assets

Stock: Asset Management & Custody Banks
Age 8.9y

MCap 8,384m
Avg Vol 421K (61.0M USD)

Beta 1.440
Volatility 32.90%

EPS (Earnings per Share)

EPS CAGR: -45.87%
EPS Trend: 9.3%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 21.59%
Rev. Trend: 78.1%

Last SUE: 0.91
Qual. Beats: 1

Dividends

Dividend Yield	1.50%
Yield on Cost 5y	2.91%
Yield CAGR 5y	11.54%
Payout Consistency	100.0%
Payout Ratio	39.7%

Risk via 5d forecast
Volatility	32.9%
Value at Risk 5%th	53.4%
Relative Tail Risk	-1.41%

Reward TTM
Sharpe Ratio	0.03
Alpha	-22.38
CAGR/Max DD	0.67

Character TTM
Hurst Exponent	0.570
Beta	1.440
Beta Downside	1.243

Drawdowns 3y
Max DD	42.68%
Mean DD	12.92%
Median DD	8.22%

Description: HLNE Hamilton Lane January 07, 2026

Hamilton Lane Inc. (NASDAQ: HLNE) is a global private-equity and venture-capital manager that deploys capital across the full spectrum of alternative strategies-from early-stage venture and growth equity to buyouts, distressed credit, mezzanine and real-asset investments. The firm primarily targets disruptive technology and innovative businesses, taking majority stakes in companies valued between $0.25 million and $100 million, and operates both primary and secondary fund-of-fund platforms across a wide geographic footprint that includes the U.S., Europe, Asia-Pacific, the Middle East, Africa and Latin America.

As of the most recent filing, Hamilton Lane reported approximately $400 billion in assets under management (AUM) and generated $1.5 billion in revenue for FY 2023, with fee-related earnings (FRE) rising roughly 12% year-over-year-a reflection of strong fundraising activity in the private-equity market, where total 2023 commitments topped $1 trillion globally. The firm’s exposure to high-growth sectors such as clean-energy infrastructure, health-tech, and fintech positions it to benefit from secular spending trends driven by ESG mandates and digital transformation, while its diversified geographic reach mitigates region-specific credit cycles.

For readers looking to deepen their quantitative assessment, a quick look at ValueRay’s platform can provide additional metrics on HLNE’s valuation multiples and peer-group performance.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income: 230.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.18 > 0.02 and ΔFCF/TA 5.34 > 1.0
NWC/Revenue: 33.37% < 20% (prev 18.95%; Δ 14.41% < -1%)
CFO/TA 0.18 > 3% & CFO 360.0m > Net Income 230.6m
Net Debt (195.9m) to EBITDA (418.6m): 0.47 < 3
Current Ratio: 39.60 > 1.5 & < 3
Outstanding Shares: last quarter (54.5m) vs 12m ago 0.58% < -2%
Gross Margin: 73.20% > 18% (prev 0.72%; Δ 7248 % > 0.5%)
Asset Turnover: 41.32% > 50% (prev 46.69%; Δ -5.37% > 0%)
Interest Coverage Ratio: 26.60 > 6 (EBITDA TTM 418.6m / Interest Expense TTM 15.4m)

Altman Z'' 3.96

A: 0.12 (Total Current Assets 240.8m - Total Current Liabilities 6.08m) / Total Assets 1.98b
B: 0.27 (Retained Earnings 535.2m / Total Assets 1.98b)
C: 0.24 (EBIT TTM 408.8m / Avg Total Assets 1.70b)
D: 0.65 (Book Value of Equity 536.5m / Total Liabilities 822.3m)
Altman-Z'' Score: 3.96 = AA

Beneish M -2.50

DSRI: 1.50 (Receivables 178.2m/112.0m, Revenue 703.4m/665.0m)
GMI: 0.98 (GM 73.20% / 71.98%)
AQI: 1.25 (AQ_t 0.85 / AQ_t-1 0.68)
SGI: 1.06 (Revenue 703.4m / 665.0m)
TATA: -0.07 (NI 230.6m - CFO 360.0m) / TA 1.98b)
Beneish M-Score: -2.50 = A

ValueRay F-Score (Strict, 0-100) 86.55

1. Piotroski: 6.0pt
2. FCF Yield: 4.06%
3. FCF Margin: 49.55%
4. Debt/Equity: 0.53
5. Debt/Ebitda: 0.47
6. ROIC - WACC: 24.37%
7. RoE: 31.25%
8. Revenue Trend: 78.11%
9. EPS Trend: 9.33%

What is the price of HLNE shares?

As of January 23, 2026, the stock is trading at USD 152.10 with a total of 354,714 shares traded.
Over the past week, the price has changed by -1.13%, over one month by +9.83%, over three months by +27.70% and over the past year by -3.57%.

Is HLNE a buy, sell or hold?

Hamilton Lane has received a consensus analysts rating of 2.83. Therefor, it is recommend to hold HLNE.

Strong Buy: 0
Buy: 0
Hold: 5
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the HLNE price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	172.6	13.5%
Analysts Target Price	172.6	13.5%
ValueRay Target Price	179.1	17.7%

HLNE Fundamental Data Overview January 22, 2026

P/E Trailing = 26.9531
P/E Forward = 24.8139
P/S = 11.4364
P/B = 7.9499
P/EG = 1.39
Revenue TTM = 703.4m USD
EBIT TTM = 408.8m USD
EBITDA TTM = 418.6m USD
Long Term Debt = 285.6m USD (from longTermDebt, last quarter)
Short Term Debt = 21.7m USD (from shortTermDebt, last fiscal year)
Debt = 436.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 195.9m USD (from netDebt column, last quarter)
Enterprise Value = 8.58b USD (8.38b + Debt 436.7m - CCE 240.8m)
Interest Coverage Ratio = 26.60 (Ebit TTM 408.8m / Interest Expense TTM 15.4m)
EV/FCF = 24.62x (Enterprise Value 8.58b / FCF TTM 348.5m)
FCF Yield = 4.06% (FCF TTM 348.5m / Enterprise Value 8.58b)
FCF Margin = 49.55% (FCF TTM 348.5m / Revenue TTM 703.4m)
Net Margin = 32.78% (Net Income TTM 230.6m / Revenue TTM 703.4m)
Gross Margin = 73.20% ((Revenue TTM 703.4m - Cost of Revenue TTM 188.5m) / Revenue TTM)
Gross Margin QoQ = 70.80% (prev 69.59%)
Tobins Q-Ratio = 4.33 (Enterprise Value 8.58b / Total Assets 1.98b)
Interest Expense / Debt = 0.88% (Interest Expense 3.83m / Debt 436.7m)
Taxrate = 11.89% (14.0m / 117.6m)
NOPAT = 360.2m (EBIT 408.8m * (1 - 11.89%))
Current Ratio = 39.60 (Total Current Assets 240.8m / Total Current Liabilities 6.08m)
Debt / Equity = 0.53 (Debt 436.7m / totalStockholderEquity, last quarter 825.8m)
Debt / EBITDA = 0.47 (Net Debt 195.9m / EBITDA 418.6m)
Debt / FCF = 0.56 (Net Debt 195.9m / FCF TTM 348.5m)
Total Stockholder Equity = 737.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.54% (Net Income 230.6m / Total Assets 1.98b)
RoE = 31.25% (Net Income TTM 230.6m / Total Stockholder Equity 737.8m)
RoCE = 39.94% (EBIT 408.8m / Capital Employed (Equity 737.8m + L.T.Debt 285.6m))
RoIC = 35.07% (NOPAT 360.2m / Invested Capital 1.03b)
WACC = 10.70% (E(8.38b)/V(8.82b) * Re(11.22%) + D(436.7m)/V(8.82b) * Rd(0.88%) * (1-Tc(0.12)))
Discount Rate = 11.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 71.03% ; FCFF base≈278.9m ; Y1≈314.8m ; Y5≈424.7m
Fair Price DCF = 103.4 (EV 4.74b - Net Debt 195.9m = Equity 4.55b / Shares 44.0m; r=10.70% [WACC]; 5y FCF grow 14.98% → 2.90% )
EPS Correlation: 9.33 | EPS CAGR: -45.87% | SUE: -4.0 | # QB: 0
Revenue Correlation: 78.11 | Revenue CAGR: 21.59% | SUE: 0.91 | # QB: 1
EPS current Year (2026-03-31): EPS=5.71 | Chg30d=+0.032 | Revisions Net=+3 | Growth EPS=+13.4% | Growth Revenue=+8.5%
EPS next Year (2027-03-31): EPS=6.28 | Chg30d=+0.069 | Revisions Net=+3 | Growth EPS=+9.9% | Growth Revenue=+17.5%

Additional Sources for HLNE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle